• FirefoxInstall the new Firefox »
  •  Dow Up0.19% Nasdaq Up0.57%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -ASE
    1.68 Up 0.03(1.82%) Mar 27, 4:06PM EDT
    |After Hours : 1.68 0.00 (0.00%) Mar 27, 4:26PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Net Income (6,865) (6,899) (7,612) (14,351)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation346  326  319  353  
    Adjustments To Net Income2,147  686  1,077  2,922  
    Changes In Accounts Receivables649  (978)100  564  
    Changes In Liabilities(923)214  (18)(1,468)
    Changes In Inventories188  247  208  119  
    Changes In Other Operating Activities(368)(304)116  79  
    Total Cash Flow From Operating Activities (4,826) (6,708) (8,420) (9,172)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(3)(3)(123)(986)
    Investments -   -   -   -  
    Other Cash flows from Investing Activities(25)(371)(7)(7)
    Total Cash Flows From Investing Activities (28) (374) (130) (993)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock0  (0)33  55  
    Net Borrowings1,763  (1)(13)3,249  
    Other Cash Flows from Financing Activities(55) -  (5)(71)
    Total Cash Flows From Financing Activities (55) (1) 15   3,232  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents (4,910) (7,083) (8,535) (6,933)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.